Your session is about to expire
← Back to Search
Health Warnings for Hookah Smoking
N/A
Recruiting
Led By Erin Sutfin, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at exit; up to 10 hours
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if health warnings in hookah cafés can reduce smoking. The study targets café customers and uses warnings to make them more aware of the risks, hoping they will smoke less.
Who is the study for?
This trial is for English-speaking individuals who plan to smoke hookah at a café and won't smoke cigarettes, cigars, or other tobacco products there. It's not open to those who've been asked to join this study elsewhere.
What is being tested?
The study is testing if health warnings at hookah cafés can make people smoke less compared to no warnings. This will be measured by the change in expired carbon monoxide levels before and after visiting the café.
What are the potential side effects?
Since this trial involves observing smoking behavior rather than a medical intervention, traditional side effects are not applicable. However, participants may experience discomfort from exposure to health warnings.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at exit; up to 10 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at exit; up to 10 hours
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes in Expired Carbon Monoxide (eCO Boost)
Other study objectives
Behavioral intention
Beliefs
Hookah use behavior
+8 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Intervention - Health WarningsExperimental Treatment1 Intervention
Cafes will display text-only warning signs
Group II: Control - No WarningsExperimental Treatment1 Intervention
No warnings posted in the hookah café
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for hookah smoking, particularly behavioral interventions like health warnings, work by increasing awareness of the health risks associated with smoking. These interventions present clear and impactful warnings that highlight the dangers, encouraging smokers to reduce or quit their use.
This approach is crucial for hookah smoking patients as it targets the psychological and cognitive aspects of addiction, helping them make informed decisions about their health and potentially leading to reduced smoking behavior.
Systematic review of interventions aimed at reducing hookah pipe use: Implications for practitioners and clinicians.Nicotine Replacement Therapy: An Overview.
Systematic review of interventions aimed at reducing hookah pipe use: Implications for practitioners and clinicians.Nicotine Replacement Therapy: An Overview.
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,403 Previous Clinical Trials
2,476,775 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,958 Previous Clinical Trials
41,111,020 Total Patients Enrolled
Erin Sutfin, PhDPrincipal InvestigatorWake Forest University Health Sciences
2 Previous Clinical Trials
2,722 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not speak English.I am 18 years old or older.I am under 18 years old.I understand the study and can answer questions about it.I understand the study and can make decisions about participating.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Control - No Warnings
- Group 2: Intervention - Health Warnings